Vaccine

What’s next in store for the world? 

According to the report, Bharat Biotech is seeking approval from the DCGI for a phase 3 research of an intra-nasal vaccination as a booster dosage. Bharat Biotech has applied to the Drug Controller General of India (DCGI) for permission to undertake a phase 3 research using its intra-nasal Covid-19 vaccine as a booster dose on